Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMP-ACT: Methotrexate Discontinuation with Tocilizumab in RA
NCT01855789Phase 3Completed
- Sponsor
- Roche
- Start
- Nov 2013
- Primary completion
- Oct 2016
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Nov 2013; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01855789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01855789.